111 related articles for article (PubMed ID: 26039562)
1. Three-Dimensional in Vitro Model to Study Osteobiology and Osteopathology.
Krishnan V; Vogler EA; Mastro AM
J Cell Biochem; 2015 Dec; 116(12):2715-23. PubMed ID: 26039562
[TBL] [Abstract][Full Text] [Related]
2. Curcumin analog UBS109 prevents bone marrow osteoblastogenesis and osteoclastogenesis disordered by coculture with breast cancer MDA-MB-231 bone metastatic cells in vitro.
Yamaguchi M; Zhu S; Weitzmann MN; Snyder JP; Shoji M
Mol Cell Biochem; 2015 Mar; 401(1-2):1-10. PubMed ID: 25416449
[TBL] [Abstract][Full Text] [Related]
3. Dynamic interaction between breast cancer cells and osteoblastic tissue: comparison of two- and three-dimensional cultures.
Krishnan V; Shuman LA; Sosnoski DM; Dhurjati R; Vogler EA; Mastro AM
J Cell Physiol; 2011 Aug; 226(8):2150-8. PubMed ID: 21520067
[TBL] [Abstract][Full Text] [Related]
4. Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment.
Sosnoski DM; Norgard RJ; Grove CD; Foster SJ; Mastro AM
Clin Exp Metastasis; 2015 Apr; 32(4):335-44. PubMed ID: 25749879
[TBL] [Abstract][Full Text] [Related]
5. Metastatic breast cancer induces an osteoblast inflammatory response.
Kinder M; Chislock E; Bussard KM; Shuman L; Mastro AM
Exp Cell Res; 2008 Jan; 314(1):173-83. PubMed ID: 17976581
[TBL] [Abstract][Full Text] [Related]
6. Metastatic breast cancer cells suppress osteoblast adhesion and differentiation.
Mercer RR; Miyasaka C; Mastro AM
Clin Exp Metastasis; 2004; 21(5):427-35. PubMed ID: 15672867
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradation.
Mastro AM; Gay CV; Welch DR; Donahue HJ; Jewell J; Mercer R; DiGirolamo D; Chislock EM; Guttridge K
J Cell Biochem; 2004 Feb; 91(2):265-76. PubMed ID: 14743387
[TBL] [Abstract][Full Text] [Related]
8. In vitro mimics of bone remodeling and the vicious cycle of cancer in bone.
Krishnan V; Vogler EA; Sosnoski DM; Mastro AM
J Cell Physiol; 2014 Apr; 229(4):453-62. PubMed ID: 24022654
[TBL] [Abstract][Full Text] [Related]
9. Cytokines secreted by bone-metastatic breast cancer cells alter the expression pattern of f-actin and reduce focal adhesion plaques in osteoblasts through PI3K.
Mercer RR; Mastro AM
Exp Cell Res; 2005 Nov; 310(2):270-81. PubMed ID: 16154565
[TBL] [Abstract][Full Text] [Related]
10. Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.
Kolb AD; Shupp AB; Mukhopadhyay D; Marini FC; Bussard KM
Breast Cancer Res; 2019 Feb; 21(1):31. PubMed ID: 30813947
[TBL] [Abstract][Full Text] [Related]
11. Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts.
Liu X; Cao M; Palomares M; Wu X; Li A; Yan W; Fong MY; Chan WC; Wang SE
Breast Cancer Res; 2018 Oct; 20(1):127. PubMed ID: 30348200
[TBL] [Abstract][Full Text] [Related]
12. The bone microenvironment in metastasis; what is special about bone?
Bussard KM; Gay CV; Mastro AM
Cancer Metastasis Rev; 2008 Mar; 27(1):41-55. PubMed ID: 18071636
[TBL] [Abstract][Full Text] [Related]
13. A three-dimensional osteogenic tissue model for the study of metastatic tumor cell interactions with bone.
Mastro AM; Vogler EA
Cancer Res; 2009 May; 69(10):4097-100. PubMed ID: 19435905
[TBL] [Abstract][Full Text] [Related]
14. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
Kitazawa S; Kitazawa R
J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883
[TBL] [Abstract][Full Text] [Related]
15. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.
Sterling JA; Edwards JR; Martin TJ; Mundy GR
Bone; 2011 Jan; 48(1):6-15. PubMed ID: 20643235
[TBL] [Abstract][Full Text] [Related]
16. Modeling the breast cancer bone metastatic niche in complex three-dimensional cocultures.
Marlow R; Dontu G
Methods Mol Biol; 2015; 1293():213-20. PubMed ID: 26040690
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
Mancino AT; Klimberg VS; Yamamoto M; Manolagas SC; Abe E
J Surg Res; 2001 Sep; 100(1):18-24. PubMed ID: 11516200
[TBL] [Abstract][Full Text] [Related]
18. MRMT-1 rat breast carcinoma cells and models of bone metastases: improvement of an in vitro system to mimic the in vivo condition.
Salamanna F; Martini L; Pagani S; Parrilli A; Giavaresi G; Maltarello MC; Fini M
Acta Histochem; 2013 Jan; 115(1):76-85. PubMed ID: 22682497
[TBL] [Abstract][Full Text] [Related]
19. Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms.
Lee JH; Kim B; Jin WJ; Kim JW; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2014 Sep; 91(1):51-60. PubMed ID: 24929117
[TBL] [Abstract][Full Text] [Related]
20. Cellular mechanisms of bone resorption in breast carcinoma.
Hunt NC; Fujikawa Y; Sabokbar A; Itonaga I; Harris A; Athanasou NA
Br J Cancer; 2001 Jul; 85(1):78-84. PubMed ID: 11437406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
